Case guide

Zantac claims: who should check my filing limit?

Ask a lawyer to check your own filing limit. It depends on the claim and court.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202613 sources

This may apply to you if

  • Preparation suggestions only; no cancer list, use-duration threshold or current firm acceptance rule is verified.
  • Describe the product, dates and diagnosis you want checked.
  • Ask a lawyer what evidence and court route apply to your own situation.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Francis J. Jones, Jr. · Superior Court of the State of Delaware · Superior Court judge signing the cited order

Finding: The April order grants judgment for defendants for consolidated complaints filed on or before December 1, 2025; later-filed evidence is addressed separately.

Jones: April14,2026 Delaware Zantac order (opens in a new tab) · Apr 14, 2026 · Checked Oct 4, 2026

The evidence and its limits

United States Food and Drug Administration · 2020

FDA assessment leading to the 2020 ranitidine withdrawal

Design:
Agency review
Participants:
Product storage and impurity assessment; no newly enrolled clinical cancer cohort
Finding:
FDA found that NDMA could increase with time and heat in the then-marketed ranitidine products.
Main limitation
The notice supports a dated product-safety action, not the dose in a person’s tablets, a cancer diagnosis or proof of individual cause. It does not evaluate the 2025 reformulated tablets.

Read the source: FDA assessment leading to the 2020 ranitidine withdrawal (opens in a new tab) · Checked Oct 4, 2026

The short answer

What filing deadline applies to my claim?
It depends on the claim and applicable law. A lawyer needs your facts to check the limit. This page does not calculate your last filing day. [2]
Did the January Delaware decision create a national cutoff?
No. The January 29, 2026 decision dismissed specified claims under the law applied there. It was not a filing rule for every court or person. [9]
Does not knowing about the recall guarantee more time?
Do not assume it does. The Delaware order applied notice rules. They did not depend only on when each person heard about the issue. [9]
Is the April evidence-order boundary my personal deadline?
No. The April order covers claims filed on or before December 1, 2025. That defines the court’s ruling. It is not every reader’s last filing date. [8]

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

Ask a lawyer to check your own filing limit. It depends on the claim and court. These dated records do not set one national deadline for all former users.

What filing deadline applies to my claim?

It depends on the claim and applicable law. A lawyer needs your facts to check the limit. This page does not calculate your last filing day.

The court’s general guidance says time limits differ. Give the lawyer the places and dates of use, diagnosis and any earlier case. Do not assume a national Zantac date answers all those legal questions.

Did the January Delaware decision create a national cutoff?

No. The January 29, 2026 decision dismissed specified claims under the law applied there. It was not a filing rule for every court or person.

The opinion concerned 277 cases in a defined firm group. It analyzed filing-time law and notice, including diagnosis and the April 2020 FDA announcement. Its exact facts and legal scope matter.

Does not knowing about the recall guarantee more time?

Do not assume it does. The Delaware order applied notice rules. They did not depend only on when each person heard about the issue.

That is a claim-specific legal finding, not advice to apply Delaware’s rule everywhere. Ask which notice, diagnosis, residence and filing facts matter under the law governing your own proposed claim.

Is the April evidence-order boundary my personal deadline?

No. The April order covers claims filed on or before December 1, 2025. That defines the court’s ruling. It is not every reader’s last filing date.

The opinion separately discusses later-filed evidence without guaranteeing a successful route. A lawyer must assess the order, actual filed papers and governing law rather than treating that boundary as an extension or invitation.

Do old federal dates or the FDA notice reset the clock?

Do not use them as a new personal deadline. The federal order sets steps for defined cases. FDA’s withdrawal was a safety action.

FDA considered impurity changes with time and heat, not your legal accrual date. The federal case-management record also does not certify the latest orders or every appeal. Ask which current record governs your case.

What should I bring to a time-limit review?

Prepare dated care reports, medicine-use notes and any earlier case papers. Ask the provider about missing covered records. Clearly mark what you do not know.

Access has exceptions and a helper may need authority. Ask which legal step is needed while records are gathered. A request for contact or copies is not itself a filed case or an assumed extension.

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. ABA Model Rule 1.5: feesABA Model Rule 1.5: fees
  2. Southern District of New York: time limitsSouthern District of New York: time limits · court
  3. 45 CFR 164.524: access to health records45 CFR 164.524: access to health records · regulator
  4. FDA: April2020 ranitidine withdrawal requestFDA: April2020 ranitidine withdrawal request · regulator
  5. FDA: reformulated ranitidine approvalFDA: reformulated ranitidine approval · regulator
  6. You: original multinational ranitidine cancer cohortYou: original multinational ranitidine cancer cohort · study
  7. Wang: original Taiwan ranitidine cohortWang: original Taiwan ranitidine cohort · study
  8. Jones: April14,2026 Delaware Zantac orderJones: April14,2026 Delaware Zantac order · court
  9. Jones: January29,2026 Delaware time-limit rulingJones: January29,2026 Delaware time-limit ruling · court
  10. GSK announced agreements with 10 plaintiff firms representing ~80,000 claimants (93% of pending US state-court Zantac cases) to pay up to $2.2 billion in aggregate, with full implementation expected by end of H1 2025; GSK admitted no liability. GSK also agreed to pay $70 million to resolve the Valisure qui tam complaint. Verified from GSK's own press statement.us.gsk.com · Oct 9, 2024
  11. Sanofi agreed to pay more than $100 million to settle ~4,000 Zantac cancer suits in state courts outside Delaware — the first major resolution in the litigation, averaging more than $25,000 per claim per Bloomberg's reporting (republished by Insurance Journal, Apr 23, 2024; deal announced earlier that month). Sanofi denied liability; 70,000+ suits then remained, mostly in Delaware.insurancejournal.com · Apr 23, 2024 · study
  12. MDL 2924 (S.D. Fla., Judge Robin L. Rosenberg) omnibus Daubert order (Doc 6120, 341 pages): ALL defendants' Daubert motions on general causation GRANTED and defendants' summary judgment motion GRANTED — plaintiffs 'fail to produce admissible primary evidence of general causation' that ranitidine causes cancer, ending the federal MDL claims. Verified from the court order itself.gsk.com · Dec 6, 2022 · court
  13. Federal court: February 14, 2023 Zantac order 81

Checked against 10 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026